New perspective of GABA as an inhibitor of formation of advanced lipoxidation end-products: it's interaction with malondiadehyde.

In this research, the obtained evidences support the hypothesis that gamma-aminobutyric acid (r-aminobutyric acid, GABA) can trap malondialdehyde (MDA) indirectly or directly. In vitro, reaction between GABA with fatty acid, which can be confirmed by detecting the formation and yield of MDA and the consumption of GABA, shows that GABA can trap the reactive intermediates during lipid peroxidation. Further study of the direct reaction between GABA and MDA indicated that GABA reacts readily with MDA under supraphysiological conditions to form different products. A nonfluorescent enamine (product 1) and a lipofuscin-like fluorescent 1,4-dihydropyridine (product 2) were obtained experimentally from reaction of equimolar of GABA+MDA and were detected by means of high performance liquid chromatography (HPLC) separation for the reaction mixtures at 48 h. We proposed a mechanism for the formation of these products from oxidation of polyunsaturated fatty acids (PUFA) to the reaction of GABA and MDA. The results suggest that the scavenging effects of GABA on reactive carbonyl compounds may play an important role in inhibiting the formation of advanced lipoxidation end-products (ALEs), and GABA, as a potent antioxidant or additive, is a novel functional factor for nutraceuticals.

[1]  K. Kikugawa,et al.  Studies on Peroxidized Lipids. I. Interaction of Malondialdehyde with Secondary Amines and Its Relevance to Nitrosamine Formation , 1980 .

[2]  K. Kikugawa,et al.  Studies on Peroxidized Lipids. II. Fluorescent Products Relevant to Aging Pigments derived from Malondialdehyde and Methylamine , 1981 .

[3]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[4]  K. Kikugawa,et al.  Involvement of lipid oxidation products in the formation of fluorescent and cross-linked proteins. , 1987, Chemistry and physics of lipids.

[5]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[6]  A. Napolitano,et al.  Reaction of malondialdehyde with amine neurotransmitters. Formation and oxidation chemistry of fluorescent 1,4-dihydropyridine adducts , 1995 .

[7]  D. Yin,et al.  Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. , 1996, Free radical biology & medicine.

[8]  T. Osawa,et al.  A novel fluorescent malondialdehyde-lysine adduct , 1996 .

[9]  L. Klassen,et al.  Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long‐term ethanol administration , 1996, Hepatology.

[10]  E. Stadtman,et al.  Protein Oxidation in Aging, Disease, and Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[11]  G. Poli,et al.  Oxidative damage and fibrogenesis. , 1997, Free radical biology & medicine.

[12]  L. Klassen,et al.  Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay. , 1997, Chemical research in toxicology.

[13]  A. Jenkins,et al.  Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. , 1997, The Biochemical journal.

[14]  D. Slatter,et al.  Formation of a dihydropyridine derivative as a potential cross‐link derived from malondialdehyde in physiological systems , 1998, FEBS letters.

[15]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[16]  M. Beal,et al.  Oxidative Stress in Huntington's Disease , 1999, Brain pathology.

[17]  J. Crowley,et al.  The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.

[18]  T. Miyata,et al.  Relevance of oxidative and carbonyl stress to long-term uremic complications. , 2000, Kidney international. Supplement.

[19]  O. Kajimoto,et al.  Effect of the defatted rice germ enriched with GABA for sleeplessness, depression, autonomic disorder by oral administration , 2000 .

[20]  A. Jenkins,et al.  Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions , 2000, The Journal of Biological Chemistry.

[21]  M. Tiku,et al.  Evidence Linking Chondrocyte Lipid Peroxidation to Cartilage Matrix Protein Degradation , 2000, The Journal of Biological Chemistry.

[22]  A. Leventhal,et al.  GABA and Its Agonists Improved Visual Cortical Function in Senescent Monkeys , 2003, Science.

[23]  Roberto Colombo,et al.  Protein carbonylation in human diseases. , 2003, Trends in molecular medicine.

[24]  P. Clarkson,et al.  Oxidative stress, exercise, and antioxidant supplementation. , 2003, Toxicology.

[25]  L. Marnett,et al.  A novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine. , 2004, Chemical research in toxicology.

[26]  Y. Yamori,et al.  Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar–Kyoto rats , 2004, British Journal of Nutrition.

[27]  L. Zitvogel,et al.  In vivo veritas , 2005, Nature Biotechnology.

[28]  N. He,et al.  A novel preparation of nanocapsules from alginate-oligochitosan. , 2007, Journal of nanoscience and nanotechnology.

[29]  J. Ramos-Loyo,et al.  Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics. , 2007, Journal of psychiatric research.

[30]  Mijun Peng,et al.  New functions of glucosamine as a scavenger of the lipid peroxidation product malondialdehyde. , 2007, Chemical research in toxicology.

[31]  Xiangrui Li,et al.  Decreased proportion of GABA neurons accompanies age-related degradation of neuronal function in cat striate cortex , 2008, Brain Research Bulletin.

[32]  R. LoPachin,et al.  Molecular Mechanisms of the Conjugated α,β-Unsaturated Carbonyl Derivatives: Relevance to Neurotoxicity and Neurodegenerative Diseases , 2008 .

[33]  R. Ahmad,et al.  Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia. , 2008, In vivo.

[34]  N. He,et al.  Chitosan/sodium tripolyphosphate nanoparticles: preparation, characterization and application as drug carrier. , 2009, Journal of biomedical nanotechnology.

[35]  Yuquan Wei,et al.  A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan. , 2009, Journal of nanoscience and nanotechnology.

[36]  A. Maitra,et al.  Magnesium phosphate nanoparticles can be efficiently used in vitro and in vivo as non-viral vectors for targeted gene delivery. , 2009, Journal of biomedical nanotechnology.

[37]  L. Jorgensen,et al.  Analysis of protein physical stability in lipid based delivery systems--the challenges of lipid drug delivery systems. , 2009, Journal of biomedical nanotechnology.

[38]  Yuquan Wei,et al.  Transdermal anaesthesia with lidocaine nano-formulation pretreated with low-frequency ultrasound in rats model. , 2009, Journal of nanoscience and nanotechnology.

[39]  Kemin Wang,et al.  A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. , 2009, Journal of biomedical nanotechnology.

[40]  I. Gaivão,et al.  A note on regulatory concerns and toxicity assessment in lipid-based delivery systems (LDS). , 2009, Journal of biomedical nanotechnology.

[41]  O. Mykhaylyk,et al.  Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI. , 2009, Journal of biomedical nanotechnology.

[42]  R. Murthy,et al.  Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery. , 2009, Journal of biomedical nanotechnology.

[43]  Chi-Tang Ho,et al.  Trapping effects of green and black tea extracts on peroxidation-derived carbonyl substances of seal blubber oil. , 2009, Journal of agricultural and food chemistry.

[44]  V. Patravale,et al.  Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. , 2009, Journal of biomedical nanotechnology.

[45]  M. Alonso,et al.  Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer. , 2009, Journal of biomedical nanotechnology.

[46]  M. Ricci,et al.  Lipid nanoparticles for drug delivery to the brain: in vivo veritas. , 2009, Journal of biomedical nanotechnology.

[47]  Li Yang,et al.  Co-delivery honokiol and doxorubicin in MPEG-PLA nanoparticles. , 2010, Journal of nanoscience and nanotechnology.

[48]  S. Yılmaz,et al.  Carbon nanotubes to deliver drug molecules. , 2010, Journal of biomedical nanotechnology.

[49]  N. He,et al.  Preparation, characterization and applications of low-molecular-weight alginate-oligochitosan nanocapsules. , 2010, Nanoscale.

[50]  N. He,et al.  Erythropoietin Nanopariticles: Therapy for Cerebral Ischemic Injury and Metabolize in Kidney and Liver , 2010 .

[51]  N. He,et al.  Therapy for cerebral ischemic injury with erythropoietin-containing nanoparticles. , 2010, Journal of nanoscience and nanotechnology.

[52]  I. About,et al.  Controlled release carriers of growth factors FGF-2 and TGFbeta1: synthesis, characterization and kinetic modelling. , 2010, Journal of biomedical nanotechnology.

[53]  M. Sivakumar,et al.  Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. , 2010, Journal of biomedical nanotechnology.

[54]  Xinlong Wang,et al.  Preparation and characterization of n-hydroxyapatite/PCL-pluronic-PCL nanocomposites for tissue engineering. , 2010, Journal of nanoscience and nanotechnology.

[55]  Xinrong Liu,et al.  Auger-mediated cytotoxicity of cancer cells in culture by an 125I-antisense oligomer delivered as a three-component streptavidin nanoparticle. , 2010, Journal of biomedical nanotechnology.